Teicoplanin (Sanofi Pharmaceuticals, Paris, France) was proven to potently avoid the entry of Ebola envelope pseudotyped viruses in to the cytoplasm, and in addition comes with an inhibitory influence on transcription-as good as replication-competent virus-like contaminants in the reduced micromolar range (IC50, 330?nM)
Teicoplanin (Sanofi Pharmaceuticals, Paris, France) was proven to potently avoid the entry of Ebola envelope pseudotyped viruses in to the cytoplasm, and in addition comes with an inhibitory influence on…